Albuterol Sulfate A Comprehensive Overview of CAS 51022-70-9
Albuterol sulfate, designated by the Chemical Abstracts Service (CAS) number 51022-70-9, is a well-known short-acting beta-agonist primarily used in the management of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). This medication acts as a bronchodilator, relaxing the muscles of the airways and facilitating easier breathing.
Chemical Composition and Properties
Albuterol sulfate is the sulfate salt form of albuterol. Its molecular formula is C13H21N, and it has a molecular weight of approximately 239.32 g/mol. The compound is characterized by its ability to bind with beta-2 adrenergic receptors in the lungs, leading to smooth muscle relaxation and dilation of the bronchial passages. As a result, patients experience relief from wheezing, shortness of breath, and chest tightness.
Manufacturing Process
The production of albuterol sulfate involves several steps in a controlled environment to ensure purity and efficacy. Leading pharmaceutical factories employ stringent quality control measures to meet the standards set by regulatory bodies. The manufacturing process begins with the synthesis of albuterol, which is then converted to its sulfate form. Chemical reaction conditions such as temperature, pressure, and pH are meticulously monitored. The final product is then crystallized, purified, and formulated into various dosage forms, including inhalers, nebulizers, and oral solutions.
Pharmaceutical Applications
Albuterol sulfate is predominantly prescribed for alleviating acute asthma attacks and managing chronic asthma symptoms. Patients often use inhalers for quick relief, as the onset of action is typically within minutes. Additionally, albuterol sulfate may be indicated for other conditions that cause bronchospasms, such as bronchitis and emphysema.
Safety and Side Effects
While albuterol sulfate is generally considered safe when used as directed, it may cause side effects in some patients. Common side effects include tachycardia, jitteriness, headache, and muscle cramps. Awareness and education regarding proper usage are essential to minimize these effects. Patients must also use the medication strictly according to prescribed guidelines to avoid potential complications.
Conclusion
In summary, albuterol sulfate (CAS 51022-70-9) is a vital therapeutic agent in respiratory medicine. Its effectiveness as a bronchodilator has made it a staple in the treatment of asthma and COPD. Through rigorous manufacturing processes and comprehensive patient education, pharmaceutical factories ensure that this medication remains safe and effective for those in need. As research and development continue, advancements in the formulation and delivery of albuterol sulfate may further improve the quality of life for patients with respiratory disorders.